According to the COSMIC database of mutations in cancer, SLC31A1 is mutated in less than 1% of samples, reaching 2.1% in HCC, 2.0% in CCA, and 1.8% in endometrial carcinoma[147]. This evidence concerns the gene SLC31A1 and cancer.